Income Statement Monash IVF Group Limited
Equities
MVF
AU000000MVF3
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7300 AUD | 0.00% |
|
-2.01% | -0.68% |
| 20/04 | Deals of the day-Mergers and acquisitions | RE |
| 20/04 | WHSP Holdings Limited and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited. | CI |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 184M | 192M | 214M | 255M | 272M | |||||
Other Revenues, Total | - | - | - | 265K | - | |||||
Total Revenues | 184M | 192M | 214M | 255M | 272M | |||||
Cost of Goods Sold, Total | 117M | 126M | 141M | 169M | 182M | |||||
Gross Profit | 66.4M | 66.48M | 72.83M | 85.76M | 90.31M | |||||
Selling General & Admin Expenses, Total | 14.3M | 18.41M | 18.21M | 20.65M | 23.82M | |||||
Depreciation & Amortization - (IS) | 10.7M | 12.35M | 12.88M | 18.58M | 22.02M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 2.19M | 2.43M | 2.46M | - | - | |||||
Other Operating Expenses | 5.19M | 4.92M | 4.28M | 6.62M | 306K | |||||
Other Operating Expenses, Total | 32.38M | 38.12M | 37.84M | 45.85M | 46.14M | |||||
Operating Income | 34.01M | 28.37M | 35M | 39.92M | 44.17M | |||||
Interest Expense, Total | -2.45M | -2.15M | -3.3M | -5.37M | -7.39M | |||||
Interest And Investment Income | 1K | 4K | 25K | 56K | 101K | |||||
Net Interest Expenses | -2.45M | -2.15M | -3.28M | -5.31M | -7.29M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 31.56M | 26.22M | 31.72M | 34.61M | 36.88M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | -1.88M | -762K | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | -761K | |||||
Insurance Settlements | - | - | - | 19.9M | - | |||||
Legal Settlements | - | - | - | -64.4M | - | |||||
Other Unusual Items | 4.38M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 35.94M | 26.22M | 29.84M | -10.66M | 36.12M | |||||
Income Tax Expense | 10.44M | 7.72M | 7.87M | -4.71M | 10.45M | |||||
Earnings From Continuing Operations | 25.5M | 18.5M | 21.97M | -5.95M | 25.68M | |||||
Net Income to Company | 25.5M | 18.5M | 21.97M | -5.95M | 25.68M | |||||
Minority Interest | -357K | -96K | -127K | -578K | -668K | |||||
Net Income - (IS) | 25.15M | 18.41M | 21.84M | -6.53M | 25.01M | |||||
Net Income to Common Incl Extra Items | 25.15M | 18.41M | 21.84M | -6.53M | 25.01M | |||||
Net Income to Common Excl. Extra Items | 25.15M | 18.41M | 21.84M | -6.53M | 25.01M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.06 | 0.05 | 0.06 | -0.02 | 0.06 | |||||
Basic EPS - Continuing Operations | 0.06 | 0.05 | 0.06 | -0.02 | 0.06 | |||||
Basic Weighted Average Shares Outstanding | 390M | 390M | 390M | 390M | 390M | |||||
Net EPS - Diluted | 0.06 | 0.05 | 0.06 | -0.02 | 0.06 | |||||
Diluted EPS - Continuing Operations | 0.06 | 0.05 | 0.06 | -0.02 | 0.06 | |||||
Diluted Weighted Average Shares Outstanding | 391M | 392M | 392M | 390M | 391M | |||||
Normalized Basic EPS | 0.05 | 0.04 | 0.05 | 0.05 | 0.06 | |||||
Normalized Diluted EPS | 0.05 | 0.04 | 0.05 | 0.05 | 0.06 | |||||
Dividend Per Share | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 | |||||
Payout Ratio | 52.23 | 91.02 | 78.5 | -280.73 | 79.46 | |||||
Supplemental Items | ||||||||||
EBITDA | 38.21M | 33.12M | 40.4M | 46.59M | 53.01M | |||||
EBITA | 34.01M | 28.37M | 35M | 39.92M | 44.17M | |||||
EBIT | 34.01M | 28.37M | 35M | 39.92M | 44.17M | |||||
EBITDAR | 38.3M | 33.19M | 40.41M | - | - | |||||
Effective Tax Rate - (Ratio) | 29.03 | 29.44 | 26.38 | 44.17 | 28.92 | |||||
Total Current Taxes | 11.24M | 7.78M | 6.43M | 10.6M | 1.28M | |||||
Total Deferred Taxes | -894K | -305K | 1.36M | -15.05M | 9.09M | |||||
Normalized Net Income | 19.37M | 16.29M | 19.7M | 21.05M | 22.38M | |||||
Interest on Long-Term Debt | 2.45M | 2.15M | 3.3M | 5.37M | 7.39M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 6.39M | 6.43M | 6.92M | 7.72M | 8.06M | |||||
Selling and Marketing Expenses | 6.39M | 6.43M | 6.92M | 7.72M | 8.06M | |||||
General and Administrative Expenses | 7.92M | 11.97M | 11.29M | 12.94M | 15.76M | |||||
Net Rental Expense, Total | 89K | 73K | 9K | - | - | |||||
Imputed Operating Lease Interest Expense | 33.72K | 20.39K | 2.68K | - | - | |||||
Imputed Operating Lease Depreciation | 55.28K | 52.61K | 6.32K | - | - | |||||
Stock-Based Comp., COGS (Total) | 114K | 251K | 318K | 405K | 767K | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 114K | 251K | 318K | 405K | 767K |
- Stock Market
- Equities
- MVF Stock
- Financials Monash IVF Group Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















